344 related articles for article (PubMed ID: 21522029)
1. Cell surface receptors in malignant glioma.
Li YM; Hall WA
Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
[TBL] [Abstract][Full Text] [Related]
2. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
3. [Molecular-targeted therapy for malignant glioma].
Yamanaka R
Brain Nerve; 2009 Feb; 61(2):177-88. PubMed ID: 19235468
[TBL] [Abstract][Full Text] [Related]
4. Emerging targeted treatments for malignant glioma.
Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of EGFR in malignant gliomas.
Ye F; Gao Q; Cai MJ
Expert Opin Ther Targets; 2010 Mar; 14(3):303-16. PubMed ID: 20148717
[TBL] [Abstract][Full Text] [Related]
6. Molecularly targeted therapies for malignant gliomas: advances and challenges.
Penas-Prado M; Gilbert MR
Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for malignant gliomas.
Kreisl TN
Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
[TBL] [Abstract][Full Text] [Related]
8. New molecular targets in malignant gliomas.
de Groot JF; Gilbert MR
Curr Opin Neurol; 2007 Dec; 20(6):712-8. PubMed ID: 17992095
[TBL] [Abstract][Full Text] [Related]
9. Novel therapies for malignant gliomas: a local affair?
Rainov NG; Söling A; Heidecke V
Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
[TBL] [Abstract][Full Text] [Related]
10. Targeting malignant glioma survival signalling to improve clinical outcomes.
Wong ML; Kaye AH; Hovens CM
J Clin Neurosci; 2007 Apr; 14(4):301-8. PubMed ID: 17276069
[TBL] [Abstract][Full Text] [Related]
11. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
[TBL] [Abstract][Full Text] [Related]
12. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
[TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
Hall WA; Sherr GT
Neurosurg Focus; 2006 Apr; 20(4):E10. PubMed ID: 16709015
[TBL] [Abstract][Full Text] [Related]
15. [New glioma therapy using specific microRNAs].
Halle B; Andersen C; Schulz MK; Kristensen BW
Ugeskr Laeger; 2012 Mar; 174(10):630-3. PubMed ID: 22395010
[TBL] [Abstract][Full Text] [Related]
16. Treatment of adults with recurrent malignant glioma.
Nabors LB; Fiveash J
Expert Rev Neurother; 2005 Jul; 5(4):509-14. PubMed ID: 16026234
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
[TBL] [Abstract][Full Text] [Related]
18. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
Karpel-Massler G; Schmidt U; Unterberg A; Halatsch ME
Mol Cancer Res; 2009 Jul; 7(7):1000-12. PubMed ID: 19584260
[TBL] [Abstract][Full Text] [Related]
20. Role of tyrosine kinase inhibitors in the management of high-grade gliomas.
Ahluwalia MS; Patel M; Peereboom DM
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1739-48. PubMed ID: 22050023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]